Harper Molly sold CPRX
July 15, 2026 · Form 4 insider transaction
Harper Molly sold 3,694 shares of Catalyst Pharmaceuticals Inc at $31.50 per share, a transaction worth $116.4K. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,694
Price
$31.50
Total value
$116.4K
InsiderHarper Molly
Role—
SecurityCommon Stock, par value $0.001 per share
Transaction codeD: Disposition to the issuer
Transaction dateJuly 15, 2026
Filing dateJuly 17, 2026
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported securities were disposed of in connection with the consummation of the acquisition of the Issuer by Angelini Pharma S.p.A. (the "Merger")